| The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer (NCT06915714) | Sun Yat-sen University | 2024-06-02 |
| A Prospective Study: Sintilimab and R-CHOP in PMBCL Treatment (NCT06412068) | Sun Yat-sen University | 2024-06-01 |
| TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer (NCT06415318) | Sun Yat-sen University | 2024-05-31 |
| Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma (NCT06445088) | Sun Yat-sen University | 2024-05-29 |
| Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer (NCT06441565) | Sun Yat-sen University | 2024-05-24 |
| A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients (NCT06569485) | Sun Yat-sen University | 2024-05-23 |
| Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases (NCT06542159) | Sun Yat-sen University | 2024-05-22 |
| bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma (NCT06070636) | Sun Yat-sen University | 2024-05-20 |
| bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC (NCT06061276) | Sun Yat-sen University | 2024-05-20 |
| Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma (NCT06516133) | Sun Yat-sen University | 2024-05-17 |
| Prebiotics and the Management of Hyperuricemia (NCT06420401) | Sun Yat-sen University | 2024-05-15 |
| BAI-BACE for Advanced Lung Squamous Cell Carcinoma (NCT06377735) | Sun Yat-sen University | 2024-05-01 |
| Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their Spouses (NCT06326437) | Sun Yat-sen University | 2024-05-01 |
| Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer (NCT06383663) | Sun Yat-sen University | 2024-05-01 |
| PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC (NCT06396637) | Sun Yat-sen University | 2024-04-30 |
| A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB (NCT06781151) | Sun Yat-sen University | 2024-04-24 |
| A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT06233864) | Sun Yat-sen University | 2024-04-17 |
| Individualized Elective Neck Irradiation in NPC Patients (NCT06241612) | Sun Yat-sen University | 2024-04-16 |
| A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery (NCT06369597) | Sun Yat-sen University | 2024-04-15 |
| Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402) (NCT06313190) | Sun Yat-sen University | 2024-04-05 |
| Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients (NCT06303089) | Sun Yat-sen University | 2024-04-05 |
| Factors Associated With Posttransplant Cardiac Outcomes (NCT06290154) | Sun Yat-sen University | 2024-04-01 |
| Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter Study (NCT06356441) | Sun Yat-sen University | 2024-04-01 |
| Adolescents' Non-suicidal Behavior and Perception of Parents' Negative Emotional Expression and Family Communication (NCT06290115) | Sun Yat-sen University | 2024-04-01 |
| Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma. (NCT06533267) | Sun Yat-sen University | 2024-03-25 |
| TPC Versus GP Induction Chemotherapy for Nasopharyngeal Carcinoma (NCT06301165) | Sun Yat-sen University | 2024-03-19 |
| De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma (NCT06313450) | Sun Yat-sen University | 2024-03-04 |
| Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) (NCT06143748) | Sun Yat-sen University | 2024-03-02 |
| Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response (NCT06239727) | Sun Yat-sen University | 2024-03-01 |
| Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis (NCT06582940) | Sun Yat-sen University | 2024-03-01 |
| Myeloprotection With Trilaciclib in Pan-cancer Population (NCT06297811) | Sun Yat-sen University | 2024-03-01 |
| Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER) (NCT06227286) | Sun Yat-sen University | 2024-03-01 |
| Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007) (NCT06187597) | Sun Yat-sen University | 2024-03-01 |
| Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06281886) | Sun Yat-sen University | 2024-02-15 |
| Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases (NCT06265350) | Sun Yat-sen University | 2024-02-02 |
| Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations (NCT06054191) | Sun Yat-sen University | 2024-02-01 |
| A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT06241599) | Sun Yat-sen University | 2024-02-01 |
| Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study (NCT07583511) | Sun Yat-sen University | 2024-02-01 |
| Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50) (NCT06733051) | Sun Yat-sen University | 2024-01-27 |
| Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer (NCT06268652) | Sun Yat-sen University | 2024-01-15 |
| Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM (NCT06208371) | Sun Yat-sen University | 2024-01-15 |
| IC Plus Low-dose Radiation Plus Cadonilimab in LANPC (NCT05941741) | Sun Yat-sen University | 2024-01-10 |
| Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study (NCT06881225) | Sun Yat-sen University | 2024-01-01 |
| High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis (NCT06812871) | Sun Yat-sen University | 2024-01-01 |
| The Cold Ischemia Robot-assisted Partial Nephrectomy (NCT07326280) | Sun Yat-sen University | 2024-01-01 |
| Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy (NCT05965531) | Sun Yat-sen University | 2024-01-01 |
| Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study (NCT05457829) | Sun Yat-sen University | 2023-12-30 |
| FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial (NCT06201065) | Sun Yat-sen University | 2023-12-26 |
| Toripalimab,Celecoxib and Regorafenib in the Treatment of Refractory Advanced Colorectal Cancer (NCT05933980) | Sun Yat-sen University | 2023-12-19 |
| Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy (NCT06170021) | Sun Yat-sen University | 2023-12-18 |
| The Effect of Sodium Fluoride Application on the Prevention of Radiation Caries in NPC Patients (NCT06174012) | Sun Yat-sen University | 2023-12-15 |
| A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma (NCT06143579) | Sun Yat-sen University | 2023-12-15 |
| The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites (NCT06433869) | Sun Yat-sen University | 2023-12-14 |
| SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx (NCT06219980) | Sun Yat-sen University | 2023-12-07 |
| Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC (NCT06435013) | Sun Yat-sen University | 2023-12-01 |
| Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation (NCT05975307) | Sun Yat-sen University | 2023-12-01 |
| Health Status and the Need for Social Return of Drug Abusers in Guangdong Province (NCT06132555) | Sun Yat-sen University | 2023-11-15 |
| The Effects of a Large Language Model on Clinical Questioning Skills (NCT06229379) | Sun Yat-sen University | 2023-11-13 |
| Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma (NCT06129955) | Sun Yat-sen University | 2023-11-11 |
| Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer (NCT05959356) | Sun Yat-sen University | 2023-11-09 |
| Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma (NCT05930665) | Sun Yat-sen University | 2023-11-01 |
| Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy (NCT06099951) | Sun Yat-sen University | 2023-11-01 |
| Liposomal Bupivacaine vs Ropivacaine for TAPBs (NCT06430112) | Sun Yat-sen University | 2023-11-01 |
| Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC (NCT06041477) | Sun Yat-sen University | 2023-10-31 |
| Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer (NCT05980689) | Sun Yat-sen University | 2023-10-24 |
| Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE) (NCT05988372) | Sun Yat-sen University | 2023-10-23 |
| Effect of the PIEB Versus CEI on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy (NCT05930405) | Sun Yat-sen University | 2023-10-20 |
| First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer (NCT06063070) | Sun Yat-sen University | 2023-10-18 |
| Impact of an Educational Video on Satisfaction After Glaucoma Surgery (NCT03958929) | Sun Yat-sen University | 2023-10-10 |
| Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy (NCT06092957) | Sun Yat-sen University | 2023-10-09 |
| Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma (NCT05949931) | Sun Yat-sen University | 2023-10-01 |
| Evaluation of Phacogoniotomy in Medically-controlled POAG (NCT06201455) | Sun Yat-sen University | 2023-09-28 |
| Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery (NCT06262581) | Sun Yat-sen University | 2023-09-23 |
| Efficacy and Safety of Tocilizumab for TAO (NCT06087731) | Sun Yat-sen University | 2023-09-23 |
| Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus (NCT06291753) | Sun Yat-sen University | 2023-09-22 |
| A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC (NCT05773105) | Sun Yat-sen University | 2023-09-19 |
| The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy (NCT06472739) | Sun Yat-sen University | 2023-09-15 |
| Effect of Health Education on Promoting Influenza Vaccination Health Literacy (NCT06048406) | Sun Yat-sen University | 2023-09-11 |
| Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma (NCT05979961) | Sun Yat-sen University | 2023-09-07 |
| Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma (NCT05969158) | Sun Yat-sen University | 2023-09-04 |
| Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS) (NCT06195202) | Sun Yat-sen University | 2023-09-01 |
| Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients (NCT06043999) | Sun Yat-sen University | 2023-09-01 |
| Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC (NCT06138496) | Sun Yat-sen University | 2023-09-01 |
| Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT05807880) | Sun Yat-sen University | 2023-09-01 |
| Effectiveness of Using Interactive Consulting System to Enhance Informed Choice (NCT04246346) | Sun Yat-sen University | 2023-09-01 |
| Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. (NCT06020885) | Sun Yat-sen University | 2023-08-31 |
| A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant (NCT05997459) | Sun Yat-sen University | 2023-08-25 |
| Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy (NCT05962502) | Sun Yat-sen University | 2023-08-24 |
| Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY) (NCT06577792) | Sun Yat-sen University | 2023-08-16 |
| Linperlisib in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma (NCT05949944) | Sun Yat-sen University | 2023-08-15 |
| Prospective Observational Study to Predict Severe Oral Mucositis Associated With Chemoradiotherapy in Nasopharyngeal Carcinoma Based on Deep Learning (NCT06032767) | Sun Yat-sen University | 2023-08-14 |
| Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC (NCT05997719) | Sun Yat-sen University | 2023-08-10 |
| Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma (NCT05780372) | Sun Yat-sen University | 2023-08-08 |
| Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes (NCT07003191) | Sun Yat-sen University | 2023-08-02 |
| Utilization of Transanal Endoscopy in the Treatment of Anastomotic Stenosis (NCT06036862) | Sun Yat-sen University | 2023-08-01 |
| Crisaborole Ointment for Skin Toxicity Induced by Cetuximab (NCT06118047) | Sun Yat-sen University | 2023-08-01 |
| MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer (NCT06204484) | Sun Yat-sen University | 2023-07-26 |
| The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC (NCT06139419) | Sun Yat-sen University | 2023-07-25 |
| RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer (NCT05578287) | Sun Yat-sen University | 2023-07-18 |
| Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer (NCT05571644) | Sun Yat-sen University | 2023-07-10 |